As of 14 Oct 2026, Umoja Biopharma has raised $100M across 1 verified round on record; latest: $100 million Series C led by DCVC Bio and Double Point Ventures, announced 14 Jan 2025.
Umoja Biopharma, a clinical-stage leader developing in vivo CAR T cell therapies.
2 sources
Sources agree on the Series C, $100 million amount, January 14, 2025 announcement date, leads, and named participants.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series C [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-01-14 | DCVC Bio, Double Point Ventures | No recent discussion |
2 sources [ VERIFIED ] read against 2 sources Sources agree on the Series C, $100 million amount, January 14, 2025 announcement date, leads, and named participants. | ||||